The Healthcare Distribution Management Association has named two new VPs representing its government affairs team — Kristen Freitas and Gary Riddle.
The U.S. Food and Drug Administration approved two treatments for irritable bowel syndrome with diarrhea (IBS-D) on Wednesday.
Mack Elevation Forum introduced a new serial digital commentary to help fine tune the process of developing innovation strategy on Thursday.
J&J tests the "avalanche theory" of healthcare costs, finding that health starts declining at an accelerating rate after age 45.
Appeals court forces Actavis to keep its Alzheimer's treatment Namenda IR on the market.
Acquisition target Perrigo recently filed a complaint to Irish Takeover Panel regarding Mylan proposal.
Specialized manufacturers are gearing up for a robust trade out of generic biosimilar approvals, Kalorama reported last week.
Aurobindo Pharma has submitted an abbreviated new drug application for dolutegravir 50 mg to the Food and Drug Administration for the treatment of HIV.
The 21st Century Cures legislation would foster drug development.
The Food and Drug Administration has approved Boehringer Ingelheim, Inc.'s Stiolto Respimat (tiotropium bromide and olodaterol), a once-daily inhaler meant to treat obstructed airflow in patients, the company announced Tuesday.